• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m6A修饰对癌症中非编码RNA的影响

Ramifications of m6A Modification on ncRNAs in Cancer.

作者信息

Mehmood Rashid

机构信息

Department of Life Sciences, College of Science and General Studies, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.

出版信息

Curr Genomics. 2024 May 31;25(3):158-170. doi: 10.2174/0113892029296712240405053201. Epub 2024 Apr 9.

DOI:10.2174/0113892029296712240405053201
PMID:39087001
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11288162/
Abstract

N6-methyladenosine (m6A) is an RNA modification wherein the N6-position of adenosine is methylated. It is one of the most prevalent internal modifications of RNA and regulates various aspects of RNA metabolism. M6A is deposited by m6A methyltransferases, removed by m6A demethylases, and recognized by reader proteins, which modulate splicing, export, translation, and stability of the modified mRNA. Recent evidence suggests that various classes of non- coding RNAs (ncRNAs), including microRNAs (miRNAs), circular RNAs (circRNAs), and long con-coding RNAs (lncRNAs), are also targeted by this modification. Depending on the ncRNA species, m6A may affect the processing, stability, or localization of these molecules. The m6A- modified ncRNAs are implicated in a number of diseases, including cancer. In this review, the author summarizes the role of mA modification in the regulation and functions of ncRNAs in tumor development. Moreover, the potential applications in cancer prognosis and therapeutics are discussed.

摘要

N6-甲基腺苷(m6A)是一种RNA修饰,其中腺苷的N6位被甲基化。它是RNA最普遍的内部修饰之一,调节RNA代谢的各个方面。m6A由m6A甲基转移酶沉积,由m6A去甲基化酶去除,并被读取蛋白识别,这些蛋白调节修饰后mRNA的剪接、输出、翻译和稳定性。最近的证据表明,包括微小RNA(miRNA)、环状RNA(circRNA)和长链非编码RNA(lncRNA)在内的各类非编码RNA(ncRNA)也受到这种修饰的靶向作用。根据ncRNA的种类,m6A可能会影响这些分子的加工、稳定性或定位。m6A修饰的ncRNA与包括癌症在内的多种疾病有关。在这篇综述中,作者总结了m6A修饰在肿瘤发生过程中对ncRNA的调控作用及功能。此外,还讨论了其在癌症预后和治疗中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a1/11288162/5ca87d1930cf/CG-25-158_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a1/11288162/f35aaf424708/CG-25-158_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a1/11288162/5ca87d1930cf/CG-25-158_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a1/11288162/f35aaf424708/CG-25-158_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a1/11288162/5ca87d1930cf/CG-25-158_F2.jpg

相似文献

1
Ramifications of m6A Modification on ncRNAs in Cancer.m6A修饰对癌症中非编码RNA的影响
Curr Genomics. 2024 May 31;25(3):158-170. doi: 10.2174/0113892029296712240405053201. Epub 2024 Apr 9.
2
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.m6A甲基化修饰与非编码RNA之间的相互作用及其对肿瘤细胞的影响概述
Transl Cancer Res. 2024 Jun 30;13(6):3106-3125. doi: 10.21037/tcr-23-2401. Epub 2024 Jun 27.
3
The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.泌尿系统肿瘤中非编码 RNA-分子靶点网络与 N6-甲基腺苷修饰的关系。
Cell Death Dis. 2024 Apr 17;15(4):275. doi: 10.1038/s41419-024-06664-z.
4
N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.N6-甲基腺苷(m6A)修饰在骨肉瘤中的作用:表达、功能及与非编码 RNA 的相互作用——最新综述
Epigenetics. 2023 Dec;18(1):2260213. doi: 10.1080/15592294.2023.2260213. Epub 2023 Sep 28.
5
Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.参与MAFLD发生发展的环状RNA、非编码RNA和N6-甲基腺苷
Noncoding RNA. 2024 Feb 5;10(1):11. doi: 10.3390/ncrna10010011.
6
Novel insights into the interaction between N6-methyladenosine modification and circular RNA.N6-甲基腺苷修饰与环状RNA相互作用的新见解。
Mol Ther Nucleic Acids. 2022 Jan 10;27:824-837. doi: 10.1016/j.omtn.2022.01.007. eCollection 2022 Mar 8.
7
The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.N6-甲基腺苷修饰的非编码RNA在人类癌症病理过程中的作用。
Cell Death Discov. 2022 Jul 18;8(1):325. doi: 10.1038/s41420-022-01113-2.
8
The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.m6A 修饰与非编码 RNA 在癌症干性调控中的相互作用:机制、信号通路及临床意义。
Int J Biol Sci. 2021 Jun 26;17(11):2718-2736. doi: 10.7150/ijbs.60641. eCollection 2021.
9
Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.环状 RNA 和 N6-甲基腺苷(m6A)修饰对癌症生物学的影响。
Biomed Pharmacother. 2023 Mar;159:114260. doi: 10.1016/j.biopha.2023.114260. Epub 2023 Jan 17.
10
Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.m6A 修饰与肿瘤微环境中非编码 RNA 的串扰。
Int J Biol Sci. 2023 Apr 17;19(7):2198-2219. doi: 10.7150/ijbs.79651. eCollection 2023.

本文引用的文献

1
miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.miR-33a-3p 通过调控 METTL3 介导的 AREG 稳定性改变 EMT 抑制胰腺癌侵袭转移
Sci Rep. 2023 Aug 21;13(1):13587. doi: 10.1038/s41598-023-39506-7.
2
Structure-Based Design of Inhibitors of the mA-RNA Writer Enzyme METTL3.基于结构的mRNA书写酶METTL3抑制剂设计
ACS Bio Med Chem Au. 2023 Jun 14;3(4):359-370. doi: 10.1021/acsbiomedchemau.3c00023. eCollection 2023 Aug 16.
3
m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
m6A 基因型和预后特征评估急性髓系白血病患者的预后。
BMC Med Genomics. 2023 Aug 18;16(1):191. doi: 10.1186/s12920-023-01629-1.
4
Going circular: history, present, and future of circRNAs in cancer.环状 RNA 与癌症:历史、现状与未来。
Oncogene. 2023 Sep;42(38):2783-2800. doi: 10.1038/s41388-023-02780-w. Epub 2023 Aug 16.
5
The current advances of lncRNAs in breast cancer immunobiology research.长链非编码 RNA 在乳腺癌免疫生物学研究中的最新进展。
Front Immunol. 2023 Jun 5;14:1194300. doi: 10.3389/fimmu.2023.1194300. eCollection 2023.
6
HNRNPA2B1-mediated mA modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.HNRNPA2B1 介导的长非编码 RNA MEG3 的 mA 修饰通过调节 miR-21-5p/PTEN 轴促进非小细胞肺癌的发生和转移。
J Transl Med. 2023 Jun 12;21(1):382. doi: 10.1186/s12967-023-04190-8.
7
Mettl14-mediated mA modification ensures the cell-cycle progression of late-born retinal progenitor cells.Mettl14 介导的 mA 修饰确保了晚期出生的视网膜祖细胞的细胞周期进程。
Cell Rep. 2023 Jun 27;42(6):112596. doi: 10.1016/j.celrep.2023.112596. Epub 2023 Jun 1.
8
The role of m6A methylation in therapy resistance in cancer.m6A 甲基化在癌症治疗抵抗中的作用。
Mol Cancer. 2023 Jun 1;22(1):91. doi: 10.1186/s12943-023-01782-2.
9
Biological functions and applications of circRNAs-next generation of RNA-based therapy.环状RNA的生物学功能与应用——基于RNA的新一代疗法
J Mol Cell Biol. 2023 Nov 27;15(5). doi: 10.1093/jmcb/mjad031.
10
YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer.YTHDC1 正向调控 PTEN 表达,在膀胱癌顺铂耐药中发挥关键作用。
Cell Prolif. 2023 Jul;56(7):e13404. doi: 10.1111/cpr.13404. Epub 2023 Apr 17.